Lung Transplantation clinical trials

Explore recruiting lung transplantation clinical trials.

Recruiting lung transplantation studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Lung Transplantation trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Randomized, Double-Blind, Placebo_Controlled Study to Evaluate Sotatercept When Added to Maximum Tolerated Background Therapy in Participants With Pulmonary Arterial Hypertension (PAH) World Health Organization (WHO) Functional Class (FC) III or FC IV at High Risk of Mortality

Belgium, Netherlands, Germany, Italy, France, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

REVOLUTION; Randomized controlled trial comparing immediate versus extended release tacrolimus; reducing calcineurin inhibitor related toxicity in lung transplantation patients

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

An investigation of clinical outcomes and inflammatory response to heparin free extracorporeal membrane oxygenation support during clinical lung transplantation – a prospective double-blind randomised feasibility study. “Zero-Hep”

Austria

Therapeutic use (Phase IV) EU CTIS Study details

A randomized, double-blind, placebo-controlled, parallel group, Phase 3 study, followed by open-label extensions, to evaluate the efficacy of oral belumosudil in adult participants with chronic lung allograft dysfunction (CLAD) following bilateral lung transplantation

Denmark, Italy, Spain, Austria, Netherlands, Hungary +8 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Long-term Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease

Greece, France, Italy, Belgium, Denmark, Germany +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Investigate the Efficacy and Safety of MBS2320 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

France, Spain, Italy, Germany, Greece, Hungary

Therapeutic exploratory (Phase II) EU CTIS Study details

Lung Transplantation trials by city

Lung Transplantation in Toronto Lung Transplantation in Vancouver Lung Transplantation in Montreal Lung Transplantation in Calgary Lung Transplantation in Edmonton Lung Transplantation in Ottawa Lung Transplantation in Winnipeg Lung Transplantation in Quebec City Lung Transplantation in Hamilton Lung Transplantation in Kitchener Lung Transplantation in London Lung Transplantation in Halifax Lung Transplantation in New York Lung Transplantation in Los Angeles Lung Transplantation in Chicago Lung Transplantation in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease